Cardiomyocyte Proteome Remodeling due to Isoproterenol-Induced Cardiac Hypertrophy during the Compensated Phase
- PMID: 32506788
- DOI: 10.1002/prca.202000017
Cardiomyocyte Proteome Remodeling due to Isoproterenol-Induced Cardiac Hypertrophy during the Compensated Phase
Abstract
Purpose: Although the pathophysiological response of cardiac tissue to pro-hypertrophic stimulus is well characterized, a comprehensive characterization of the molecular events underlying the pathological hypertrophy in cardiomyocytes during the early compensated cardiac hypertrophy is currently lacking.
Experimental design: A quantitative label-free proteomic analysis of cardiomyocytes isolated was conducted from mice treated subcutaneously with isoproterenol (ISO) during 7 days in comparison with cardiomyocytes from control animals (CT).
Results: Canonical pathway analysis of dysregulated proteins indicated that ISO-hypertrophy drives the activation of actin cytoskeleton and integrin-linked kinase (ILK) signaling, and inhibition of the sirtuin signaling. Alteration in cardiac contractile function and calcium signaling are predicted as downstream effects of ISO-hypertrophy probably due to the upregulation of key elements such as myosin-7 (MYH7). Confocal microscopy corroborated that indeed ISO-treatment led to increased abundance of MYH7. Potential early markers for cardiac hypertrophy as APBB1, GOLGA4, HOOK1, KATNA1, KIFBP, MAN2B2, and SLC16A1 are also reported.
Conclusions and clinical relevance: The data consist in a complete molecular mapping of ISO-induced compensated cardiac hypertrophy model at cardiomyocyte level. Marker candidates reported may assist early diagnosis of cardiac hypertrophy and ultimately heart failure.
Keywords: cardiac hypertrophy; cardiomyocyte; isoproterenol; mass spectrometry; proteomics.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.Cardiovasc Res. 2021 May 25;117(6):1532-1545. doi: 10.1093/cvr/cvaa233. Cardiovasc Res. 2021. PMID: 32717063 Free PMC article.
-
Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.Cardiovasc Toxicol. 2020 Jun;20(3):235-248. doi: 10.1007/s12012-019-09548-3. Cardiovasc Toxicol. 2020. PMID: 31485892
-
β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.J Mol Cell Cardiol. 2012 Jan;52(1):206-18. doi: 10.1016/j.yjmcc.2011.09.022. Epub 2011 Oct 8. J Mol Cell Cardiol. 2012. PMID: 22004899 Free PMC article.
-
Actin-Binding Proteins in Cardiac Hypertrophy.Cells. 2022 Nov 11;11(22):3566. doi: 10.3390/cells11223566. Cells. 2022. PMID: 36428995 Free PMC article. Review.
-
Pathological cardiac remodeling seen by the eyes of proteomics.Biochim Biophys Acta Proteins Proteom. 2021 Jun;1869(6):140622. doi: 10.1016/j.bbapap.2021.140622. Epub 2021 Feb 16. Biochim Biophys Acta Proteins Proteom. 2021. PMID: 33607275 Review.
Cited by
-
Comprehensive analysis of geographic and breed-purpose influences on genetic diversity and inherited disease risk in the Doberman dog breed.Canine Med Genet. 2023 Jun 5;10(1):7. doi: 10.1186/s40575-023-00130-3. Canine Med Genet. 2023. PMID: 37277858 Free PMC article.
-
Cardioproteomics: Insights on Cardiovascular Diseases.Adv Exp Med Biol. 2024;1443:159-171. doi: 10.1007/978-3-031-50624-6_8. Adv Exp Med Biol. 2024. PMID: 38409420 Review.
-
Cell-based therapies reverse the heart failure-altered right ventricular proteome.Res Sq [Preprint]. 2024 Sep 6:rs.3.rs-4752035. doi: 10.21203/rs.3.rs-4752035/v1. Res Sq. 2024. Update in: Stem Cell Res Ther. 2024 Nov 13;15(1):420. doi: 10.1186/s13287-024-04009-3. PMID: 39281857 Free PMC article. Updated. Preprint.
-
Dapagliflozin mitigates cellular stress and inflammation through PI3K/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived β cells.Cardiovasc Diabetol. 2024 Oct 29;23(1):388. doi: 10.1186/s12933-024-02481-y. Cardiovasc Diabetol. 2024. PMID: 39472869 Free PMC article.
-
Cardiomyocyte intercellular signalling increases oxidative stress and reprograms the global- and phospho-proteome of cardiac fibroblasts.J Extracell Biol. 2023 Nov 30;2(12):e125. doi: 10.1002/jex2.125. eCollection 2023 Dec. J Extracell Biol. 2023. PMID: 38938901 Free PMC article.
References
-
- a) M. Writing Group, D. Mozaffarian, E. J. Benjamin, A. S. Go, D. K. Arnett, M. J. Blaha, M. Cushman, S. R. Das, S. de Ferranti, J. P. Despres, H. J. Fullerton, V. J. Howard, M. D. Huffman, C. R. Isasi, M. C. Jimenez, S. E. Judd, B. M. Kissela, J. H. Lichtman, L. D. Lisabeth, S. Liu, R. H. Mackey, D. J. Magid, D. K. McGuire, E. R. Mohler, 3rd, C. S. Moy, P. Muntner, M. E. Mussolino, K. Nasir, R. W. Neumar, G. Nichol, L. Palaniappan, D. K. Pandey, M. J. Reeves, C. J. Rodriguez, W. Rosamond, P. D. Sorlie, J. Stein, A. Towfighi, T. N. Turan, S. S. Virani, D. Woo, R. W. Yeh, M. B. Turner, C. American Heart Association Statistics, S. Stroke Statistics, Circulation 2016, 133, e38;
-
- b) M. Shenasa, H. Shenasa, Int. J. Cardiol. 2017, 237, 60.
-
- S. V. Raman, J. Am. Coll. Cardiol. 2010, 55, 91.
-
- W. Grossman, D. Jones, L. P. McLaurin, J. Clin. Invest. 1975, 56, 56.
-
- J. W. Adams, Y. Sakata, M. G. Davis, V. P. Sah, Y. Wang, S. B. Liggett, K. R. Chien, J. H. Brown, G. W. Dorn, 2nd, Proc. Natl. Acad. Sci. USA 1998, 95, 10140.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources